Vincent Rotello to CRISPR-Cas Systems
This is a "connection" page, showing publications Vincent Rotello has written about CRISPR-Cas Systems.
Connection Strength
1.530
-
Ray M, Lee YW, Hardie J, Mout R, Yesilbag Tonga G, Farkas ME, Rotello VM. CRISPRed Macrophages for Cell-Based Cancer Immunotherapy. Bioconjug Chem. 2018 02 21; 29(2):445-450.
Score: 0.449
-
Mout R, Ray M, Lee YW, Scaletti F, Rotello VM. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges. Bioconjug Chem. 2017 Apr 19; 28(4):880-884.
Score: 0.423
-
Mout R, Ray M, Yesilbag Tonga G, Lee YW, Tay T, Sasaki K, Rotello VM. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing. ACS Nano. 2017 03 28; 11(3):2452-2458.
Score: 0.420
-
?i?ek YA, Luther DC, Kretzmann JA, Rotello VM. Advances in CRISPR/Cas9 Technology for in Vivo Translation. Biol Pharm Bull. 2019; 42(3):304-311.
Score: 0.120
-
Luther DC, Lee YW, Nagaraj H, Scaletti F, Rotello VM. Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges. Expert Opin Drug Deliv. 2018 09; 15(9):905-913.
Score: 0.117